Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonlinear association of methylmalonic acid with chronic obstructive pulmonary disease and the mediating role of systemic inflammation: A population-based study.

Respiratory medicine·2026
Same author

Confinement-Driven CO Spillover in CuAg@MSN Tandem Catalysts Boosts C<sub>2</sub> Selectivity Toward Electrocatalytic CO<sub>2</sub> Reduction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia.

Functional & integrative genomics·2026
Same author

Remote spin-state engineering of Fe<sub>2</sub>Ni clusters <i>via</i> a graphdiyne-MXene heterointerface for boosted N<sub>2</sub> reduction.

Chemical communications (Cambridge, England)·2026
Same author

Carboxymethyl chitosan crosslinked self-assembled collagen hydrogel protects against radiation-induced skin injury by modulating iron homeostasis.

Biomaterials advances·2026
Same author

ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Related Experiment Video

Updated: Oct 17, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K

PER2: a potential molecular marker for hematological malignancies.

Huihui Jiang1, Xin Yang1, Miaomiao Mi1

  • 1Department of Laboratory Center, Yantai Yuhuangding Hospital Affiliated to Qingdao University, 20 Yuhuangding East Road, Yantai, 264000, Shandong, China.

Molecular Biology Reports
|October 13, 2021
PubMed
Summary

The circadian gene PER2 plays a key role in hematological malignancies like leukemia. Understanding PER2

Keywords:
Circadian geneLeukemiaLymphomaPER2

More Related Videos

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
09:05

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

5.3K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K

Related Experiment Videos

Last Updated: Oct 17, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
09:05

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

Published on: June 29, 2020

5.3K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K

Area of Science:

  • Chronobiology
  • Molecular Biology
  • Oncology

Background:

  • Circadian rhythms regulate fundamental biological processes, including metabolism and cell proliferation.
  • Circadian genes are increasingly implicated in the development and progression of hematological malignancies.
  • PER2 is a core circadian rhythm gene crucial for biological clock regulation.

Purpose of the Study:

  • To review the current research on the role of the PER2 gene in hematological malignancies.
  • To elucidate the specific involvement of PER2 in leukemia.
  • To offer insights for improved clinical diagnosis and treatment strategies.

Main Methods:

  • Literature review of studies on PER2 and hematological malignancies.
  • Analysis of research progress concerning PER2's function in leukemia.
  • Synthesis of findings related to PER2's impact on disease progression.

Main Results:

  • PER2's significant role in the circadian regulation of biological processes.
  • Evidence linking PER2 dysregulation to the pathogenesis of hematological cancers.
  • Specific examples of PER2's involvement in leukemia development and progression.

Conclusions:

  • PER2 is a critical factor in the context of hematological malignancies.
  • Further investigation into PER2 could lead to novel diagnostic markers.
  • Targeting PER2 pathways may offer new therapeutic avenues for leukemia patients.